{
    "code": "02021892",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02021892",
    "time": "2019-11-22 03:02:37",
    "許可證字號": "衛署藥輸字第021892號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "111\/09\/18",
    "發證日期": "86\/09\/18",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202189208",
    "中文品名": "諾億亞內服液劑８０毫克\/毫升",
    "英文品名": "NORVIR(RITONAVIR ORAL SOLUTION)80MG\/ML",
    "適應症": "可和核甘類似物合用或單獨使用來治療人類免疫缺乏病毒（ＨＩＶ）的感染。",
    "劑型": "170內服液劑",
    "包裝": "240公撮瓶裝",
    "": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "-->\r\n                    \r\n                        \r\n                            標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "06須由醫師處方使用",
    "藥品分類": "",
    "主製造廠": {
        "限制項目": "02輸　入 1Q不得輸入",
        "申請商名稱": "6401101591  瑞士商艾伯維藥品有限公司台灣分公司",
        "申請商地址": "台北市中山區民生東路三段49號及51號15樓",
        "主製造廠": ""
    },
    "CCC號列": "30049072004 抗人類免疫缺乏病毒感染用藥Drugs for anti human immunodeficiency virus (HIV) infections",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "0818001100",
            "成分名稱": "RITONAVIR",
            "含量描述": "",
            "含量": "80.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "附件三 Norvir Oral Solution_依核定草本-108-10-23.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02021892&Seq=010&Type=9"
        },
        {
            "title": "020218920005.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02021892&Seq=005&Type=8"
        }
    ]
}